FIbromyalgia anD GenetIcs Subgroups (FIDGIS)

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

January 17, 2022

Study Completion Date

January 17, 2022

Conditions
Fibromyalgia
Interventions
DEVICE

Electrophysiological measurement of reflex nociceptive flexion threshold (RIII reflex) using Nicolet Vicking device

"This intervention measures the response to electrical stimulation of the sural nerve using a pair of percutaneous electrodes placed at the external malleolar retro passage of the nerve (2 cm apart) and connected to the stimulation device (Nicolet Vicking). Reflex muscle responses will be collected using surface electrodes placed on the femoral biceps muscle of the participant and connected to an Electromyogram recording device.~The RIII will be determined twice (rest period between each 10-minute). In order to induce the reflex nociceptive flexion response, repeated cutaneous electrical stimulations (30 to 40) will be applied at the level of the sural nerve following a variable interval of 6 to 10 seconds in order to overcome the phenomena of habituation and predictability. Each stimulus test will consist of a single rectangular pulse of 0.5 ms, of variable intensity (0-100mA) until a reflex nociceptive flexion threshold is detected or a maximum current of 100 mA is reached"

Trial Locations (1)

63000

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
collaborator

Service de pharmacologie et toxicologie cliniques, Hôpitaux Universitaire Genève, Rue Gabrielle Perret-Gentil 4, 1205 Genève, SUISSE

UNKNOWN

collaborator

Association des Fibromyalgiques d'Auvergne, 19 Place de la Résistance, 63800 Cournon d'Auvergne, FRANCE

UNKNOWN

lead

University Hospital, Clermont-Ferrand

OTHER

NCT04624581 - FIbromyalgia anD GenetIcs Subgroups (FIDGIS) | Biotech Hunter | Biotech Hunter